(Q46619100)

23 December 2017

title

Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres (English)

1 reference

23 December 2017

author name string

P Windrum

1

1 reference

23 December 2017

T C M Morris

2

1 reference

23 December 2017

M B Drake

3

1 reference

23 December 2017

D Niederwieser

4

1 reference

23 December 2017

T Ruutu

5

1 reference

23 December 2017

EBMT Chronic Leukaemia Working Party Complications Subcommittee

6

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

23 December 2017

Bone Marrow Transplantation

published in

1 reference

23 December 2017

volume

36

1 reference

23 December 2017

issue

7

1 reference

23 December 2017

page(s)

601-603

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705100

exact match

0 references

cites work

Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705100

Severe neurotoxicity because of dimethyl sulphoxide following peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705100

Long-term storage at -80 degrees C of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide as the sole cryoprotectant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705100

No differences in colony formation of peripheral blood stem cells frozen with 5% or 10% dimethyl sulfoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705100

Uncontrolled-rate freezing and storage at -80 degrees C, with only 3.5-percent DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705100

The role of depletion of dimethyl sulfoxide before autografting: on hematologic recovery, side effects, and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705100

Fatal cardiac arrhythmia after infusion of dimethyl sulfoxide-cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705100

7 January 2021

Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705100

7 January 2021

Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705100

7 January 2021

Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705100

7 January 2021

Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705100

7 January 2021

What really cures in autologous bone marrow transplantation? A possible role for dimethylsulfoxide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705100

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705100

1 reference

23 December 2017

PubMed ID

16044141

1 reference

23 December 2017